Genetically Engineered Hepatitis C Virus-like Particles (HCV-LPs) Tagged with SP94 Peptide to Acquire Selectivity to Liver Cancer Cells via Grp78
Targeted cancer therapy is a challenging area that includes multiple chemical and biological vehicles. Virus-like particles (VLPs) combine safety and efficacy in their roles as potential vaccines and drug delivery vehicles. In this study, we propose a novel drug delivery system based on HCV-LPs engi...
Main Authors: | Dina Mofed, Mohamed A. Wahba, Tamer Z. Salem |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/44/8/256 |
Similar Items
-
Co-downregulation of GRP78 and GRP94 induces apoptosis and inhibits migration in prostate cancer cells
by: Lu Tong, et al.
Published: (2019-07-01) -
Overexpression of molecular chaperons GRP78 and GRP94 in CD44hi/CD24lo breast cancer stem cells
by: Babak Nami, et al.
Published: (2016-06-01) -
Protective Effects of Glucose-Related Protein 78 and 94 on Cisplatin-Mediated Ototoxicity
by: Junyeong Yi, et al.
Published: (2020-08-01) -
Physiological Roles of the Autoantibodies to the 78-Kilodalton Glucose-Regulated Protein (GRP78) in Cancer and Autoimmune Diseases
by: Mario Gonzalez-Gronow, et al.
Published: (2022-05-01) -
Prediction of HCV E2 association with the host-cell chaperone, GRP78
by: Wael Elshemey, et al.
Published: (2023-01-01)